Similar articles

• The Immunobiogram, a Novel In Vitro Assay to Evaluate Treatment Resistance in Patients Receiving Immunosuppressive Therapy.

  Portoles JM, Jimenez C, Janeiro D, Lopez-Oliva MO, Ortega-Carrion A, Blanquez D, Arribas L, Gomez C, Diez T, Pascual J, Portero I. Portoles JM, et al. Front Immunol. 2021 Jan 25;11:618202. doi: 10.3389/fimmu.2020.618202. eCollection 2020. Front Immunol. 2021. PMID: 33569062 Free PMC article.
• The Immunobiogram, a novel in vitro diagnostic test to measure the pharmacodynamic response to immunosuppressive therapy in kidney transplant patients.

  Pascual J, Jiménez C, Krajewska M, Seron D, Kotton CN, Portolés J, Witzke O, Sorensen SS, Andrés A, Crespo M, Paz-Artal E, Díez T, Ortega A, Portero I. Pascual J, et al. Transpl Immunol. 2022 Dec;75:101711. doi: 10.1016/j.trim.2022.101711. Epub 2022 Sep 9. Transpl Immunol. 2022. PMID: 36096417
• The IMBG Test for Evaluating the Pharmacodynamic Response to Immunosuppressive Therapy in Kidney Transplant Patients: Current Evidence and Future Applications.

  Pascual J, Crespo M, Portoles J, Jimenez C, Ortega-Carrion A, Diez T, Portero I. Pascual J, et al. Int J Mol Sci. 2023 Mar 8;24(6):5201. doi: 10.3390/ijms24065201. Int J Mol Sci. 2023. PMID: 36982276 Free PMC article.
• A proposal for management of rheumatic disease patients with hepatitis B virus infection receiving immunosuppressive therapy.

  Harigai M, Mochida S, Mimura T, Koike T, Miyasaka N. Harigai M, et al. Mod Rheumatol. 2014 Jan;24(1):1-7. doi: 10.3109/14397595.2013.852834. Mod Rheumatol. 2014. PMID: 24261752 Review.
• Prevention of Hepatitis B Reactivation in Patients Receiving Immunosuppressive Therapy: a Case Series and Appraisal of Society Guidelines.

  Etienne S, Vosbeck J, Bernsmeier C, Osthoff M. Etienne S, et al. J Gen Intern Med. 2023 Feb;38(2):490-501. doi: 10.1007/s11606-022-07806-9. Epub 2022 Sep 22. J Gen Intern Med. 2023. PMID: 36138278 Free PMC article. Review.